These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 11256477)

  • 1. Selective nonpeptidic inhibitors of herpes simplex virus type 1 and human cytomegalovirus proteases.
    Matsumoto M; Misawa S; Chiba N; Takaku H; Hayashi H
    Biol Pharm Bull; 2001 Mar; 24(3):236-41. PubMed ID: 11256477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The herpesvirus protease: mechanistic studies and discovery of inhibitors of the human cytomegalovirus protease.
    Flynn DL; Becker DP; Dilworth VM; Highkin MK; Hippenmeyer PJ; Houseman KA; Levine LM; Li M; Moormann AE; Rankin A; Toth MV; Villamil CI; Wittwer AJ; Holwerda BC
    Drug Des Discov; 1997 May; 15(1):3-15. PubMed ID: 9332827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Active site cavity of herpesvirus proteases revealed by the crystal structure of herpes simplex virus protease/inhibitor complex.
    Hoog SS; Smith WW; Qiu X; Janson CA; Hellmig B; McQueney MS; O'Donnell K; O'Shannessy D; DiLella AG; Debouck C; Abdel-Meguid SS
    Biochemistry; 1997 Nov; 36(46):14023-9. PubMed ID: 9369473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contrasting effects of W781V and W780V mutations in helix N of herpes simplex virus 1 and human cytomegalovirus DNA polymerases on antiviral drug susceptibility.
    Piret J; Goyette N; Eckenroth BE; Drouot E; Götte M; Boivin G
    J Virol; 2015 Apr; 89(8):4636-44. PubMed ID: 25673718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of human cytomegalovirus proteinase by salcomine derivatives.
    Watanabe S; Konno K; Shigeta S; Yokota T
    Antivir Chem Chemother; 1998 May; 9(3):269-74. PubMed ID: 9875406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amino acid changes within conserved region III of the herpes simplex virus and human cytomegalovirus DNA polymerases confer resistance to 4-oxo-dihydroquinolines, a novel class of herpesvirus antiviral agents.
    Thomsen DR; Oien NL; Hopkins TA; Knechtel ML; Brideau RJ; Wathen MW; Homa FL
    J Virol; 2003 Feb; 77(3):1868-76. PubMed ID: 12525621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The herpesvirus proteases as targets for antiviral chemotherapy.
    Waxman L; Darke PL
    Antivir Chem Chemother; 2000 Jan; 11(1):1-22. PubMed ID: 10693650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ASP2151, a novel helicase-primase inhibitor, possesses antiviral activity against varicella-zoster virus and herpes simplex virus types 1 and 2.
    Chono K; Katsumata K; Kontani T; Kobayashi M; Sudo K; Yokota T; Konno K; Shimizu Y; Suzuki H
    J Antimicrob Chemother; 2010 Aug; 65(8):1733-41. PubMed ID: 20534624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 2-chloro-3-substituted-1,4-naphthoquinone inactivators of human cytomegalovirus protease.
    Ertl P; Cooper D; Allen G; Slater MJ
    Bioorg Med Chem Lett; 1999 Oct; 9(19):2863-6. PubMed ID: 10522707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel yeast cell-based assay to screen for inhibitors of human cytomegalovirus protease in a high-throughput format.
    Cottier V; Barberis A; Lüthi U
    Antimicrob Agents Chemother; 2006 Feb; 50(2):565-71. PubMed ID: 16436711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV integrase inhibitors block replication of alpha-, beta-, and gammaherpesviruses.
    Yan Z; Bryant KF; Gregory SM; Angelova M; Dreyfus DH; Zhao XZ; Coen DM; Burke TR; Knipe DM
    mBio; 2014 Jul; 5(4):e01318-14. PubMed ID: 24987091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Herpesvirus proteases: targets for novel antiviral drugs.
    Holwerda BC
    Antiviral Res; 1997 Jun; 35(1):1-21. PubMed ID: 9224957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro proteolytic activity and active-site identification of the human cytomegalovirus protease.
    Stevens JT; Mapelli C; Tsao J; Hail M; O'Boyle D; Weinheimer SP; Diianni CL
    Eur J Biochem; 1994 Dec; 226(2):361-7. PubMed ID: 8001553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 4-Oxo-4,7-dihydrothieno[2,3-b]pyridines as non-nucleoside inhibitors of human cytomegalovirus and related herpesvirus polymerases.
    Schnute ME; Cudahy MM; Brideau RJ; Homa FL; Hopkins TA; Knechtel ML; Oien NL; Pitts TW; Poorman RA; Wathen MW; Wieber JL
    J Med Chem; 2005 Sep; 48(18):5794-804. PubMed ID: 16134946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design of translactam HCMV protease inhibitors as potent antivirals.
    Borthwick AD
    Med Res Rev; 2005 Jul; 25(4):427-52. PubMed ID: 15789440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potent beta-lactam inhibitors of human cytomegalovirus protease.
    Yoakim C; Ogilvie WW; Cameron DR; Chabot C; Grand-Maître C; Guse I; Haché B; Kawai S; Naud J; O'Meara JA; Plante R; Déziel R
    Antivir Chem Chemother; 1998 Sep; 9(5):379-87. PubMed ID: 9875391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytomegalovirus protein substrates are not cleaved by the herpes simplex virus type 1 proteinase.
    Welch AR; Villarreal EC; Gibson W
    J Virol; 1995 Jan; 69(1):341-7. PubMed ID: 7983728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. beta-Lactam derivatives as inhibitors of human cytomegalovirus protease.
    Yoakim C; Ogilvie WW; Cameron DR; Chabot C; Guse I; Haché B; Naud J; O'Meara JA; Plante R; Déziel R
    J Med Chem; 1998 Jul; 41(15):2882-91. PubMed ID: 9667976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design and synthesis of pyrrolidine-5,5'-trans-lactams (5-oxo-hexahydropyrrolo[3,2-b]pyrroles) as novel mechanism-based inhibitors of human cytomegalovirus protease. 4. Antiviral activity and plasma stability.
    Borthwick AD; Davies DE; Ertl PF; Exall AM; Haley TM; Hart GJ; Jackson DL; Parry NR; Patikis A; Trivedi N; Weingarten GG; Woolven JM
    J Med Chem; 2003 Oct; 46(21):4428-49. PubMed ID: 14521407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro activity of the herpes simplex virus type 1 protease with peptide substrates.
    DiIanni CL; Mapelli C; Drier DA; Tsao J; Natarajan S; Riexinger D; Festin SM; Bolgar M; Yamanaka G; Weinheimer SP
    J Biol Chem; 1993 Dec; 268(34):25449-54. PubMed ID: 8244978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.